Salar Mousa: Effect of COVID-19 on Initiation of Antithrombotic Therapy Post-Stroke in Sweden
Salar Mousa, PHD Student at Örebro University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am very excited to share our newly published study examining the effect of COVID-19 pandemic on the initiation of antithrombotic therapy after stroke in Sweden.
Published in Basic and Clinical Pharmacology and Toxicology.
I would like to sincerely thank my supervisors and co-authors from Örebro University, Uppsala University and Gothenburg University for their support and work on this project.”
Title: Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post–COVID-19 in Sweden—An Interrupted Time Series Study
Authors: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, Mohammad Hossein Hajiebrahimi
Read the Full Article on Basic and Clinical Pharmacology and Toxicology
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029